Home/Damian Pharma/Ronald E. Steele
RE

Ronald E. Steele

Co-Founder and Chief Scientific Officer

Damian Pharma

Therapeutic Areas

Damian Pharma Pipeline

DrugIndicationPhase
Dexfadrostat Phosphate (DP13) & DP14 DiagnosticPrimary AldosteronismPhase 2